Rare Neurological Disease Treatment Global Market Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,490	200 Pages	The Business Research Company	February, 2025	BRC19655224

Best Price Guarantee
Price	from $4,490
Length	200 Pages
Publisher	The Business Research Company
Published Date	February, 2025
SKU	BRC19655224

Rare Neurological Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare neurological disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for rare neurological disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rare neurological disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Biologics; Small Molecules

2) By Therapy: Cognitive Behavioral Therapy; Interpersonal Psychotherapy; Cyberknife; Other Therapies

3) By Mode Of Administration: Oral; Injectable; Other Modes Of Administration

4) By Disorders: Aicardi Syndrome; Aicardi-Goutières Syndrome; Reflex Sympathetic Dystrophy Syndrome; Battaglia-Neri Syndrome; Creutzfeldt Jakob Disease; Agnosia; Other Disorders

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Drug Store; Online Pharmacies

Subsegments:

1) By Biologics: Monoclonal Antibodies; Gene Therapies; Recombinant Proteins

2) By Small Molecules: Targeted Small Molecules; Neuroprotective Agents; Anti-inflammatory Small Molecules

Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd; Bayer AG; Merck & Co. Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Rare Neurological Disease Treatment Market Characteristics
3. Rare Neurological Disease Treatment Market Trends And Strategies
4. Rare Neurological Disease Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Rare Neurological Disease Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Rare Neurological Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Rare Neurological Disease Treatment Market Growth Rate Analysis; 5.4. Global Rare Neurological Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Rare Neurological Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Rare Neurological Disease Treatment Total Addressable Market (TAM)
6. Rare Neurological Disease Treatment Market Segmentation: 6.1. Global Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Biologics; Small Molecules; 6.2. Global Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Cognitive Behavioral Therapy; Interpersonal Psychotherapy; Cyberknife; Other Therapies; 6.3. Global Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Injectable; Other Modes Of Administration; 6.4. Global Rare Neurological Disease Treatment Market, Segmentation By Disorders, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Aicardi Syndrome; Aicardi-Goutières Syndrome; Reflex Sympathetic Dystrophy Syndrome; Battaglia-Neri Syndrome; Creutzfeldt Jakob Disease; Agnosia; Other Disorders; 6.5. Global Rare Neurological Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Retail Pharmacies And Drug Store; Online Pharmacies; 6.6. Global Rare Neurological Disease Treatment Market, Sub-Segmentation Of Biologics, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Monoclonal Antibodies; Gene Therapies; Recombinant Proteins; 6.7. Global Rare Neurological Disease Treatment Market, Sub-Segmentation Of Small Molecules, By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Targeted Small Molecules; Neuroprotective Agents; Anti-inflammatory Small Molecules
7. Rare Neurological Disease Treatment Market Regional And Country Analysis: 7.1. Global Rare Neurological Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Rare Neurological Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Rare Neurological Disease Treatment Market: 8.1. Asia-Pacific Rare Neurological Disease Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Rare Neurological Disease Treatment Market: 9.1. China Rare Neurological Disease Treatment Market Overview; 9.2. China Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Rare Neurological Disease Treatment Market: 10.1. India Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Rare Neurological Disease Treatment Market: 11.1. Japan Rare Neurological Disease Treatment Market Overview; 11.2. Japan Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Rare Neurological Disease Treatment Market: 12.1. Australia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Rare Neurological Disease Treatment Market: 13.1. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Rare Neurological Disease Treatment Market: 14.1. South Korea Rare Neurological Disease Treatment Market Overview; 14.2. South Korea Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Rare Neurological Disease Treatment Market: 15.1. Western Europe Rare Neurological Disease Treatment Market Overview; 15.2. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Rare Neurological Disease Treatment Market: 16.1. UK Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Rare Neurological Disease Treatment Market: 17.1. Germany Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Rare Neurological Disease Treatment Market: 18.1. France Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Rare Neurological Disease Treatment Market: 19.1. Italy Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Rare Neurological Disease Treatment Market: 20.1. Spain Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Rare Neurological Disease Treatment Market: 21.1. Eastern Europe Rare Neurological Disease Treatment Market Overview; 21.2. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Rare Neurological Disease Treatment Market: 22.1. Russia Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Rare Neurological Disease Treatment Market: 23.1. North America Rare Neurological Disease Treatment Market Overview; 23.2. North America Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Rare Neurological Disease Treatment Market: 24.1. USA Rare Neurological Disease Treatment Market Overview; 24.2. USA Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Rare Neurological Disease Treatment Market: 25.1. Canada Rare Neurological Disease Treatment Market Overview; 25.2. Canada Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Rare Neurological Disease Treatment Market: 26.1. South America Rare Neurological Disease Treatment Market Overview; 26.2. South America Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Rare Neurological Disease Treatment Market: 27.1. Brazil Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Rare Neurological Disease Treatment Market: 28.1. Middle East Rare Neurological Disease Treatment Market Overview; 28.2. Middle East Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Rare Neurological Disease Treatment Market: 29.1. Africa Rare Neurological Disease Treatment Market Overview; 29.2. Africa Rare Neurological Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Rare Neurological Disease Treatment Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Rare Neurological Disease Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Rare Neurological Disease Treatment Market Competitive Landscape And Company Profiles: 30.1. Rare Neurological Disease Treatment Market Competitive Landscape; 30.2. Rare Neurological Disease Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Rare Neurological Disease Treatment Market Other Major And Innovative Companies: 31.1. AbbVie Inc.; 31.2. Novartis AG; 31.3. Sanofi-Aventis SA; 31.4. Bristol-Myers Squibb Company; 31.5. AstraZeneca PLC; 31.6. GlaxoSmithKline PLC; 31.7. Takeda Pharmaceutical Company Limited; 31.8. Medtronic PLC; 31.9. Teva Pharmaceutical Industries Ltd.; 31.10. CSL Limited; 31.11. Biogen Inc.; 31.12. UCB S.A.; 31.13. Eisai Co. Ltd.; 31.14. Otsuka Pharmaceutical Co. Ltd.; 31.15. Jazz Pharmaceuticals PLC
32. Global Rare Neurological Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Rare Neurological Disease Treatment Market
34. Recent Developments In The Rare Neurological Disease Treatment Market
35. Rare Neurological Disease Treatment Market High Potential Countries, Segments and Strategies: 35.1 Rare Neurological Disease Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Rare Neurological Disease Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Rare Neurological Disease Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer